Combinatorial chemopreventive strategies, in contrast to those with individual agents, show potential in terms of potentially lower toxicity and higher e‹cacy. In this study, we combined several agents and examined their suppressive eŠects on the combined lipopolysaccharide (LPS)-and interferon(IFN)-g-induced formation of proin‰ammatory mediators, including prostaglandin (PG) E 2 and tumor necrosis factor (TNF)-a, in RAW264.7 murine macrophages. The combinatorial eŠects of indomethacin W genistein (GEN) and aspirin W GEN were found to be synergistic for PGE 2 suppression, while the nimesulide W GEN combination was antagonistic. Further, while (-)-epigallocatechin gallate (EGCG) alone increased LPS W IFM-g-induced production of PGE 2 and TNF-a as well as cyclooxygenase-2 expression, the EGCG W GEN combination markedly suppressed these parameters. Our results suggest that certain chemopreventive agents act complexly and that, when used in combination, they aŠect the intracellular signaling pathways of the paired agents to exert additive, synergistic, or antagonistic eŠects.
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The processes of carcinogenesis are complex and numerous molecular events are involved, thus the number of cancer cell phenotypes is almost untold. As a result, cancer preventive strategies that use multiple agents with diŠerent action mechanisms, rather than individual agents, should provide experimental and clinical results with higher e‹cacy and lower toxicity. 1) Based on this rationale, several research groups have combined natural and synthetic agents to test this hypothesis. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] In our previous study, 12) when two agents with diŠerent modes of actions were combined at lower concentrations, synergistic eŠects for suppressing the generation of both phorbol esterinduced superoxide anion and nitric oxide induced by combined lipopolysaccharide (LPS) and interferon (IFN)-g in RAW264.7 cells were observed. Chronic in‰ammation occupies a considerable portion of cancer etiology. 13, 14) Moreover, chronic infection with bacteria, including Bartonella spp., Lawsonia intracellularis, and Citrobacter rodentium, leads to an acceleration of cell proliferation, 15) and bacterial eradication using antibiotics may be a useful remedy for the control of in‰ammation-related carcinogenesis, particularly those in the stomach 16) and liver. 17) Upon bacterial infection, a distinct biological phenomenon is the activation of in‰ammato-ry cells such as neutrophils and macrophages, which are responsible for the generation of reactive oxygen and nitrogen species, as well as proin‰ammatory mediators.
Cyclooxygenase (COX)-2, in contrast to the constitutive isoform COX-1, is an inducible enzyme that catalyzes the conversion of arachidonic acid into prostaglandin (PG)H 2 . PGE 2 , a stable and bioactive prostanoid, is then formed, and is involved in apoptosis suppression and angiogenesis induction. 18) In fact, several groups have already shown that COX-2 knockout mice are less susceptible to genetic and chemical carcinogenesis in some organs, including the colon and skin. 19, 20) Along a similar line, prostanoid receptor knockout mice developed fewer tumors than their wild-type counterparts. 21, 22) Nonsteroidal anti-in‰ammatory drugs (NSAIDs) are a large chemical group with speciˆc pharmacological properties, including COX inhibition, while tumor necrosis factor (TNF)-a, a proin‰ammatory cytokine, is involved in many aspects of in‰ammatory and carcinogenic events, 23, 24) e.g., expressions of inducible nitric oxide synthase (iNOS) 25) and COX-2, 26) via activation of nuclear factor-kappaB. 27) In this study, we investigated the combinatorial eŠects of NSAIDs and chemopreventive compounds with food origins on combined LPS-and IFN-ginduced PGE2 formation, as well as TNF-a release, from a murine macrophage line, RAW264.7.
Materials and Methods
Reagents and Cell. Dulbecco's modiˆed Eagle's medium (DMEM) and fetal bovine serum (FBS) were purchased from Gibco RBL, Rockville, NY. LPS (LPS, E. coli serotype 0127, B8) was purchased from Difco Labs (Detroit, MI) and interferon (IFN)-g came from Genzyme (Cambridge, MA). All other chemicals were purchased from Wako Pure Chemical Industries (Osaka, Japan), unless speciˆed otherwise. RAW 264.7 cells were purchased from the American Type Culture Collection, Rockville, MA.
Measurement of PGE2 and TNF-a. RAW 264.7 cells (8×10 5 cells W 2 ml) on a 60-mm dish were treated with LPS (100 ng W ml), tetrahydrobiopterin (10 mg W ml), IFN-g (100 U W ml), L-arginine (2 mM), and specied concentrations of each test compound dissolved in DMSO (0.5z, v W v). After 18 hours, the concentrations of PGE2 and TNF-a in the media were measured using commercial experimental kits (Cayman, Ann Arbor, MI; and Endogen, Inc., Woburn, MA, respectively) according to the protocol of the manufacturer. Media were used without dilution for both measurements. Levels of cytotoxicity were also measured using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays. Cells treated only with the vehicle or LPS W IFN-g were used as negative and positive controls, respectively.
Western Blotting. Western blotting for the detection of COX-2 and b-actin expressions was done as previously reported.
12) RAW 264.7 cells were stimulated in the manner described above. After the cells were washed, a boiling lysis solution was added, and then the cells were scraped from the dish, sonicated, and boiled for 10 minutes. Ten-microgram protein samples were separated on 10z polyacrylamide gels and electrophoretically transferred onto polyvinylidene di‰uoride membranes (Millipore, MA). After blocking, the membranes were incubated with a primary antibody (goat anti-rat COX-2 antibody, cross-reacts with mouse counterparts, 1:1000 dilution, Santa Cruz Biotechnology, Inc., Santa Cruz, CA) and then a secondary antibody (peroxidaseconjugated swine anti-rabbit IgG, 1:1000 dilution, Dako, Glostrup, Denmark). The blots were developed using an ECL detection kit (Amersham Life Science, Buckinghamshire, UK). The antibodies were then stripped and the blots successively re-probed with rabbit polyclonal anti-b-actin antibody (1:1000 dilution, Biochemical Technologies, Stoughton, MA), and then with peroxidase-conjugated swine anti-rabbit IgG (1:1000 dilution, Dako).
Protein Measurement. Proteins in each bioassay were measured using a DC Protein Assay kit (BioRad Laboratories, Hercules, CA) according to the protocol of the manufacturer, with g-globulin used as the standard. 
Statistical Analysis and Inhibitory Rate (IR

Results
RAW264.7 cells were stimulated with LPS W IFN-g for 18 hours, and the media concentrations of PGE2, a major and bioactive prostanoid, were measured. The individual suppressive eŠects of a dual COX inhibitor (COX-1 and COX-2), indomethacin (IND, at 20 and 5 mM), and a soybean iso‰avonoid, genistein (GEN, at 10 and 2.5 mM), on PGE2 production were examined. As shown in Fig. 1A , B, these agents showed concentration-dependent inhibition (IR＝9z-66z). Further, when IND and GEN were combined at higher concentrations (Fig. 1A) , the observed IR (75z) was less than the sum of their individual IRs (105z), however, a synergistic eŠect was seen at lower concentrations (Fig. 1B) . Conversely, when the counterpart of GEN was changed to aspirin (ASP, at 10 and 0.4 mM), another COX dual inhibitor, the combinatorial eŠect at higher concentrations (Fig. 1C) was additive, while that at lower ones was synergistic (Fig. 1D) . Nimesulide (NIM), a selective COX-2 inhibitor, was then combined with GEN at 20 and 2 mM. As shown in Fig. 2A and B, marked antagonism was seen with this combination, i.e., the diŠerences between the sum and observed IRs were 60z and 65z at higher and lower concentrations, respectively. However, the IND W NIM combination showed no synergy at either higher or lower concentrations (Fig. 2C, D) .
A green tea polyphenol, EGCG (at 10 and 0.4 mM), increased LPS W IFN-g-induced PGE2 production by 25z and 20z, respectively, as reported recently. 28) Interestingly, the addition of GEN at a concentration of 10 mM drastically hampered the adverse eŠect of EGCG, leading to an inhibition of 35z in their combination (Fig. 3A) , which was also seen at lower concentrations (Fig. 3B) . Treatment of RAW264.7 cells with LPS W IFN-g dramatically induced COX-2 protein expression, which was absent in non-treated cells, as detected by Western blotting analyses (Fig. 4A, lane 2) . Along with the results of PGE2 measurement, EGCG (at 10 mM) markedly increased COX-2 expression by 80z (Fig. 4A, lane 3, and Fig. 4B ), while GEN was suppressive (Fig. 4A , lane 4; IR＝70z). When these agents were combined, a signiˆcant suppression of COX-2 expression was observed (IR＝51z). However, their combinatorial eŠect was ambiguous at lower concentrations (Fig. 4C) .
Treatment of RAW264.7 cells with IPS W IFN-g plus EGCG (at 10 mM) led to a marked increase (by 80z) in the media level of TNF-a as compared with LPS W IFN-g (Fig. 5A ). Similar to the results shown in Fig. 4B , GEN (at 10 mM) noticeably compensated for the adverse eŠect of EGCG, though this phenomenon was not seen at lower concentrations (Fig. 5B) . To counteract the TNF-a production increase by EGCG, GEN was found to be replaceable with benzyl isothiocyanate (BITC, at 1.0 and 0.25 mM), a typical phytochemical occurring in Cruciferae plants, since the EGCG W BITC combination signiˆcantly suppressed TNF-a release by 18z, whereas the sum of IRs by the individual agents was -45z (Fig. 5C) . A similar tendency was seen even at lower concentrations (Fig. 5D) .
We next explored the possibility of an additive eŠect of a grape polyphenol, resveratrol (RES, at 50 and 2.0 mM). As shown in Fig. 6A , B, the EGCG W RES combination markedly suppressed TNF-a release only at a higher concentration, as the diŠer-ence between the sum and observed IRs was 70z. However, no such eŠect was observed in the combination of GEN and RES at either concentration (Figs. 6C, D) . In addition, the GEN W BITC combination was distinctively antagonistic at both concentrations (Fig. 7) .
Discussion
This study provides an experimental basis for combining known chemopreventive agents to achieve desirable results with higher e‹cacy and lower toxicity. NSAIDs comprise one of the most promising groups, with chemopreventive e‹cacy that has been shown in certain organs including the colon. 29) In an attempt to increase their e‹cacy and reduce toxicity, some research groups have explored the potentially beneˆcial eŠects of a combination of NSAIDs with several agents that are functionally and structurally distinct.
For example, Suganuma et al. demonstrated that a combination of green tea extract with sulindac synergistically suppressed intestinal tumor formation in Min mice.
2) Other groups have also reported that NSAIDs and an ornithine decarboxylase inhibitor had a pronounced and chemopreventive eŠect in combination, 7, 8) suggesting that the use of agents with distinct action mechanisms may be the prerequisite for synergy and e‹cacy. To test this hypothesis, we have recently done some combinatorial experiments, and found that the combination of an iNOS inhibitor and iNOS induction suppressant as well as that of a superoxide scavenger and superoxide generating enzyme suppressant generated marked activity synergism.
12) It is important to note that the present results showed for theˆrst time the beneˆcial eŠect of a combination of NSAIDs and GEN, and that a potential side eŠect of EGCG 28) may be masked by GEN. While NSAIDs inhibit COX-2 activity, GEN is recognized to attenuate COX-2 induction via a tyrosine kinase blockade. 30) As expected, the IND W GEN and ASP W GEN combinations had synergism when tested at lower concentrations in this study (Fig. 1B,  D) . However, NIM and GEN were obviously antagonistic to PGE 2 formation suppression, which was unexpected ( Fig. 2A, B) , suggesting that the combinatorial eŠect of GEN largely depends upon the type of COX inhibitor that it is paired with, namely, either dual inhibitors (IND and ASP) or a COX-2 selective one (NIM), though the molecular mechanisms involved with these diŠerences remain to be found.
EGCG, a major polyphenol of green tea, is a promising agent with chemopreventive e‹cacy in multiple organs. 31) Hong et al., however, demonstrated that EGCG increases COX-2 expression through extracellular signal-regulated protein kinase and protein tyrosine kinase signaling pathways in RAW264.7 macrophages. 32) Further, another report showed that EGCG increases tyrosine phosphorylation in hepatocytes, 33) contradicting other results, 34, 35) suggesting that the modulating eŠects of EGCG on the tyrosine phosphorylation status depend on cell types. In any case, it is of paramount importance to note that GEN is a well-known protein tyrosine kinase inhibitor that suppresses extracellular signal-regulated protein kinase activation. 36) Thus, these results raise the possibility that GEN masks the COX-2-inducing property of EGCG (Fig. 4) by perturbing EGCG-triggered kinase-activating pathways. If the in vivo adverse eŠect of EGCG can be disclosed, GEN may become an intriguing candidate to attenuate it by inhibiting tyrosine kinase.
EGCG was previously reported to suppress okadaic acid-induced TNF-a release from BALB W 3T3 cells. 31) In contrast, our results here showed that EGCG at a concentration of 10 mM markedly increased TNF-a release (Fig. 5A ), though these contradictory results may be related to the biochemical nature of the stimulants and cell types used by the two research groups. Nonetheless, it is important to note that GEN abolished the increased TNF-a release caused by EGCG, while pronounced suppression was achieved in their combination. Conversely, RES, also reported as a tyrosine kinase inhibitor, 37) showed a similar eŠect on TNF-a suppression when combined with EGCG (Fig. 6A) . Although no reports have yet addressed the tyrosine kinase inhibitory properties of the isothiocyanate class of compounds, BITC may have a similar biochemical proˆle to GEN, based on our results that it counteracted the TNF-a increasing eŠect of EGCG (Fig. 5C, D) .
In our previous study, 12) the combinatorial eŠects were synergistic when the agents were given at lower concentrations, wherein the dose of each alone did not markedly suppress free radical generation (IRº30z). However, the concentration settings for a combination may not be an essential factor for generating synergistic eŠects on PGE2 and TNF-a production, as shown in this study. On the other hand, the importance of the use of agents with distinct action mechanisms 12) was conˆrmed by our results, because the combinatorial eŠects of both COX inhibitors (IND W NIM, Fig. 2C ) as well as those of tyrosine kinase inhibitors (GEN W RES, Fig. 6C ) were antagonistic.
In conclusion, we demonstrated that a combinatorial eŠect of GEN with NSAIDs (COX dual, but not COX-2 selective, inhibitors) was synergistic to reduce PGE2 production, and that the COX-2-inducing and TNF-a-releasing activity of EGCG could be counteracted by tyrosine kinase inhibitors (GEN, RES, etc.). These results imply the beneˆcial uses of NSAIDs with certain natural chemopreventives and suggest that food phytochemical interactions are complex, as they were shown to be additive, synergistic, and antagonistic in biological systems.
